Published in:
01-03-2014 | Editorial and Commentary
Is a policy of watch and wait after a complete response following neoadjuvant treatment for locally advanced rectal adenocarcinoma justified? Should we reset the limit?
Authors:
Carlo Eugenio Vitelli, Francesco Stipa, Ugo De Paula
Published in:
Updates in Surgery
|
Issue 1/2014
Login to get access
Excerpt
Radical surgery has been considered, in the past century, the unique and more effective therapeutic option for locally advanced rectal adenocarcinoma. Standardization of surgical technique [
1] has reduced the local recurrence rates to one digit percentages, and the addition of radiation therapy treatments combined with less toxic chemotherapy regimens either pre- or post-operatively has significantly improved the short- and long-term outcomes of these patients. The systematic use of neoadjuvant therapy has led to the common observation that at least 20–30 % of patients (depending on the CHT regimen used and the timing of surgery) are completely free of tumor (CR: ypT0ypN0) in the resected specimens [
2,
3]. …